AntiCEA M3-I
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2571384
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: The trial will involve 20 adult patients with colorectal cancer, to be divided into 2 10-member groups for each dose level. One single intravenous dose of 0.3 or 1mg of fragment marked with 5-7 mCi of 131I will be administered, depending on the group.;Antibodies, Monoclonal;Radioimmunodetection;Iodine Radioisotopes;Injections, Intramuscular;131I-antiCEA M3
Primary outcome(s): Pharmaceutical safety, measuring time: 6 months.
Study Design: Allocation: Non-randomized controlled trial. Masking: Open. Control group: Uncontrolled. Assignment: Other. Purpose: Diagnostic
创建时间：
2007-05-15
